Additionally, TGF-β is reported to increase fibroblast growth factor-2 (FGF-2) production and mesenchymal stem cell (MSC) differentiation into myofibroblasts to trigger cancer proliferation and invasiveness [25,26]. The gene discussed is TGFB1; the disease is cancer.